NO993051D0 - Intranasale formuleringer for behandling av seksuelle forstyrrelser - Google Patents

Intranasale formuleringer for behandling av seksuelle forstyrrelser

Info

Publication number
NO993051D0
NO993051D0 NO993051A NO993051A NO993051D0 NO 993051 D0 NO993051 D0 NO 993051D0 NO 993051 A NO993051 A NO 993051A NO 993051 A NO993051 A NO 993051A NO 993051 D0 NO993051 D0 NO 993051D0
Authority
NO
Norway
Prior art keywords
treatment
sexual disorders
intranasal formulations
intranasal
formulations
Prior art date
Application number
NO993051A
Other languages
English (en)
Other versions
NO317365B1 (no
NO993051L (no
Inventor
Anne Billotte
Peter James Dunn
Brian Thomas Henry
Peter Vallance Marshall
Joanna Jayne Woods
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9813452.1A external-priority patent/GB9813452D0/en
Priority claimed from GBGB9820837.4A external-priority patent/GB9820837D0/en
Priority claimed from GBGB9903177.5A external-priority patent/GB9903177D0/en
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of NO993051D0 publication Critical patent/NO993051D0/no
Publication of NO993051L publication Critical patent/NO993051L/no
Publication of NO317365B1 publication Critical patent/NO317365B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
NO19993051A 1998-06-22 1999-06-21 Intranasale formuleringer for behandling av seksuelle forstyrrelser NO317365B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9813452.1A GB9813452D0 (en) 1998-06-22 1998-06-22 Pharmaceutical formulations
GBGB9820837.4A GB9820837D0 (en) 1998-09-24 1998-09-24 Pharmaceutical formulations
GBGB9903177.5A GB9903177D0 (en) 1999-02-13 1999-02-13 Pharmaceutical formulations

Publications (3)

Publication Number Publication Date
NO993051D0 true NO993051D0 (no) 1999-06-21
NO993051L NO993051L (no) 1999-12-23
NO317365B1 NO317365B1 (no) 2004-10-18

Family

ID=27269368

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993051A NO317365B1 (no) 1998-06-22 1999-06-21 Intranasale formuleringer for behandling av seksuelle forstyrrelser

Country Status (40)

Country Link
US (2) US20020040139A1 (no)
EP (1) EP0967214B1 (no)
JP (1) JP3263379B2 (no)
KR (1) KR100345824B1 (no)
AP (1) AP1178A (no)
AR (1) AR016993A1 (no)
AT (1) ATE269866T1 (no)
AU (1) AU746865B2 (no)
BG (1) BG64372B1 (no)
BR (1) BR9903273A (no)
CA (1) CA2275554C (no)
CZ (1) CZ294856B6 (no)
DE (1) DE69918222T2 (no)
DK (1) DK0967214T3 (no)
DZ (1) DZ2826A1 (no)
EA (1) EA001903B1 (no)
ES (1) ES2221733T3 (no)
GT (1) GT199900095A (no)
HN (1) HN1999000096A (no)
HR (1) HRP990195B1 (no)
HU (1) HUP9902076A3 (no)
ID (1) ID23554A (no)
IL (1) IL130539A0 (no)
IS (1) IS5085A (no)
MA (1) MA25089A1 (no)
MY (1) MY117967A (no)
NO (1) NO317365B1 (no)
NZ (1) NZ336382A (no)
OA (1) OA11069A (no)
PA (1) PA8476301A1 (no)
PE (1) PE20000702A1 (no)
PT (1) PT967214E (no)
SG (1) SG77246A1 (no)
SI (1) SI0967214T1 (no)
SK (1) SK284574B6 (no)
TN (1) TNSN99129A1 (no)
TR (1) TR199901444A2 (no)
TW (1) TWI223598B (no)
UA (1) UA59385C2 (no)
YU (1) YU29699A (no)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200591B1 (en) 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
GB9828340D0 (en) * 1998-12-22 1999-02-17 Novartis Ag Organic compounds
CA2391968A1 (en) * 1999-11-18 2001-05-25 Natco Pharma Limited An improved pharmaceutical composition for treating male erectile dysfunction
KR20010016165A (ko) * 2000-11-16 2001-03-05 정순학 성기능 장애 치료를 위한 피부에 적용하는 제제
DE10118306A1 (de) 2001-04-12 2002-10-17 Bayer Ag Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation
DE10118305A1 (de) * 2001-04-12 2002-10-17 Bayer Ag Zusammensetzungen zur nasalen Applikation
JP2005503425A (ja) 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
AU2002310086B2 (en) * 2001-05-24 2008-09-04 Alexza Pharmaceuticals, Inc. Delivery of erectile dysfunction drugs through an inhalation route
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
DE10248601B4 (de) * 2002-10-17 2006-05-24 Goldstein, Naum, Dr.habil.nat. Pharmazeutisches Mittel zur endonasalen Applikation bei der Behandlung von Krankheiten und Störungen des zentralen Nervensystems
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
US7138107B2 (en) * 2003-02-18 2006-11-21 Compellis Pharmaceuticals Inhibition of olfactory neurosensory function to treat eating disorders and obesity
US7638138B2 (en) * 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
KR100974482B1 (ko) 2003-03-27 2010-08-10 가부시키가이샤 바이오악티스 비강용 분말 약제 투약 장치
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
ATE510174T1 (de) 2003-05-21 2011-06-15 Alexza Pharmaceuticals Inc Schlag gezündete unabhängige heizeinheit
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
WO2006016530A1 (ja) * 2004-08-10 2006-02-16 Translational Research, Ltd. 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
WO2006042701A1 (de) 2004-10-18 2006-04-27 Polymun Scientific Immunbiologische Forschung Gmbh Liposomale zusammensetzung einen wirkstoff zur relaxierung glatter muskulatur enthaltend, die herstellung dieser zusammensetzung und deren therapeutische verwendung
JP2008532973A (ja) * 2005-03-09 2008-08-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬とｐｄｅ５−阻害剤に基づく新規な医薬組成物
ES2433661T3 (es) 2005-04-19 2013-12-12 Takeda Gmbh Roflumilast para el tratamiento de hipertensión pulmonar
US8506934B2 (en) 2005-04-29 2013-08-13 Robert I. Henkin Methods for detection of biological substances
CA2610668A1 (en) * 2005-08-29 2007-03-08 Teva Pharmaceutical Industries Ltd. Solid particulate tadalafil having a bimodal particle size distribution
GB0526283D0 (en) * 2005-12-23 2006-02-01 Givaudan Sa Compositions
GB0606234D0 (en) * 2006-03-29 2006-05-10 Pliva Istrazivanje I Razvoj D Pharmaceutically acceptable salts and polymorphic forms
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
US8337817B2 (en) * 2006-12-26 2012-12-25 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
US8293489B2 (en) 2007-01-31 2012-10-23 Henkin Robert I Methods for detection of biological substances
WO2008112661A2 (en) 2007-03-09 2008-09-18 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
DE102008004893A1 (de) 2008-01-17 2009-07-23 Add Technologies Ltd. Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
US20110033506A1 (en) * 2008-02-08 2011-02-10 Adel Penhasi Combination dosage form of low-dose modafinil and low-dose sildenafil
ES2586032T3 (es) 2008-03-28 2016-10-11 Hale Biopharma Ventures, Llc Administración de composiciones de benzodiazepinas
BRPI0822655A2 (pt) 2008-06-04 2015-06-30 Colgate Palmolive Co Implemento e sistema para cuidado oral
WO2009152344A2 (en) * 2008-06-11 2009-12-17 Comgenrx, Inc. Combination therapy using phosphodiesterase inhibitors
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
US8440631B2 (en) 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
US9101539B2 (en) * 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
JP2011001317A (ja) * 2009-06-19 2011-01-06 Fumakilla Ltd 鼻用洗浄剤
GB2472327B (en) * 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
WO2011141489A1 (en) 2010-05-10 2011-11-17 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
BR112012028656A2 (pt) 2010-05-10 2016-08-09 Euro Celtique Sa combinação de grânulos carregados ativos com ativos adicionais
PT3415139T (pt) 2011-06-14 2022-06-20 Neurelis Inc Administração de benzodiazepina
CN102952138B (zh) * 2011-08-17 2016-07-06 上海特化医药科技有限公司 一种吡唑并嘧啶酮化合物的盐、多晶型物及其药物组合物、制备方法和应用
GB2497933B (en) * 2011-12-21 2014-12-24 Londonpharma Ltd Drug delivery technology
US20150297601A1 (en) * 2012-10-05 2015-10-22 Robert I. Henkin Phosphodiesterase inhibitor treatment
CA2881144A1 (en) * 2012-11-09 2014-05-09 Purdue Pharma Pharmaceutical compositions comprising hydromorphone and naloxone
RU2536425C2 (ru) * 2013-01-17 2014-12-20 Общество с ограниченной ответственностью "Фармамед" Фармацевтическая композиция, содержащая силденафил цитрат, и способ ее приготовления
EP2968204B1 (en) * 2013-03-15 2019-05-15 Robert I. Henkin Phosphodiesterase inhibitors for treating taste and smell disorders
KR102194174B1 (ko) 2013-11-13 2020-12-23 유로-셀티큐 에스.에이. 통증 및 오피오이드 장 기능장애 증후군의 치료를 위한 히드로모르폰 및 날록손
US10598672B2 (en) 2014-02-18 2020-03-24 Cyrano Therapeutics, Inc. Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
NO2723977T3 (no) 2014-03-19 2018-03-10
CA2994709A1 (en) * 2015-08-03 2017-02-09 Synergistic Therapeutics, Llc Sexual dysfunction therapeutic gel
JP2019536769A (ja) * 2016-10-31 2019-12-19 スダ リミテッド 粘膜活性剤送達
CN110603033A (zh) * 2017-03-02 2019-12-20 荷兰可再生能源公司 生理活性物质的鼻内给药
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CA3086881A1 (en) 2017-12-26 2019-07-04 Ftf Pharma Private Limited Liquid oral formulations for pde v inhibitors
WO2019157099A1 (en) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Intranasal epinephrine formulations and methods for the treatment of disease
AU2019254841A1 (en) * 2018-04-16 2020-12-03 Barista Mist Pty Ltd Caffeine compositions and methods of use
SE542968C2 (en) * 2018-10-26 2020-09-22 Lindahl Anders Treatment of osteoarthritis
US20220111162A1 (en) * 2020-07-29 2022-04-14 Lido Ventures Llc Apparatus, system, and method for facilitating intranasal treatment of a patient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250534A (en) * 1990-06-20 1993-10-05 Pfizer Inc. Pyrazolopyrimidinone antianginal agents
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
DE69600784T2 (de) * 1995-11-20 1999-04-08 Lilly Co Eli Proteinkinase-C-Inhibitor
KR20010012995A (ko) * 1997-05-29 2001-02-26 모치다 에이 발기부전 치료제
AU751182B2 (en) * 1997-12-02 2002-08-08 Archimedes Development Limited Compositions for nasal administration
US6087368A (en) * 1998-06-08 2000-07-11 Bristol-Myers Squibb Company Quinazolinone inhibitors of cGMP phosphodiesterase

Also Published As

Publication number Publication date
CA2275554A1 (en) 1999-12-22
AU746865B2 (en) 2002-05-02
OA11069A (en) 2002-03-13
HU9902076D0 (en) 1999-08-30
HUP9902076A2 (hu) 2000-05-28
BG64372B1 (bg) 2004-12-30
AP1178A (en) 2003-06-30
MY117967A (en) 2004-08-30
EP0967214B1 (en) 2004-06-23
JP3263379B2 (ja) 2002-03-04
US20020040139A1 (en) 2002-04-04
NO317365B1 (no) 2004-10-18
CZ9902257A3 (cs) 2000-11-15
HUP9902076A3 (en) 2002-03-28
SK81999A3 (en) 2001-01-18
PE20000702A1 (es) 2000-08-16
NZ336382A (en) 1999-11-29
DZ2826A1 (fr) 2003-12-01
DK0967214T3 (da) 2004-09-27
JP2000034232A (ja) 2000-02-02
YU29699A (sh) 2003-02-28
HRP990195B1 (en) 2003-04-30
SI0967214T1 (en) 2004-10-31
SG77246A1 (en) 2000-12-19
PA8476301A1 (es) 2000-09-29
BR9903273A (pt) 2000-05-09
ID23554A (id) 2000-05-04
UA59385C2 (uk) 2003-09-15
ATE269866T1 (de) 2004-07-15
US20030158206A1 (en) 2003-08-21
KR20000006310A (ko) 2000-01-25
DE69918222D1 (de) 2004-07-29
GT199900095A (es) 2000-12-13
AP9901585A0 (en) 1999-06-30
HRP990195A2 (en) 2000-02-29
EA199900487A2 (ru) 1999-12-29
EA199900487A3 (ru) 2000-04-24
SK284574B6 (sk) 2005-06-02
TR199901444A2 (xx) 2000-01-21
HN1999000096A (es) 2000-12-03
NO993051L (no) 1999-12-23
MA25089A1 (fr) 2000-12-31
IS5085A (is) 1999-12-23
AR016993A1 (es) 2001-08-01
KR100345824B1 (ko) 2002-07-24
TWI223598B (en) 2004-11-11
EP0967214A1 (en) 1999-12-29
IL130539A0 (en) 2000-06-01
TNSN99129A1 (fr) 2005-11-10
CA2275554C (en) 2003-06-03
AU3579499A (en) 2000-01-06
DE69918222T2 (de) 2005-07-28
ES2221733T3 (es) 2005-01-01
EA001903B1 (ru) 2001-10-22
PT967214E (pt) 2004-08-31
BG103510A (en) 2000-01-31
CZ294856B6 (cs) 2005-03-16

Similar Documents

Publication Publication Date Title
NO993051D0 (no) Intranasale formuleringer for behandling av seksuelle forstyrrelser
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
HUP0400914A3 (en) Methods of treatment of mitochondrial disorders
ZA200401004B (en) Combination for the treatment of inflammatory disorders
NO20012995L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
ID30276A (id) Metode untuk mengobati gangguan-gangguan seksual
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
NO20020062L (no) Behandling av nevrotiske forstyrrelser
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20011892D0 (no) 3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser
PT1294710E (pt) Derivados de indole uteis para o tratamento de disturbios do snc
NO20010390D0 (no) Behandling av angstsykdommer
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
GB9816352D0 (en) The treatment of inflammatory disorders
GB9816349D0 (en) The treatment of inflammatory disorders
GB0003228D0 (en) Treatment of GI disorders
NO996166D0 (no) Fremgangsmåte for behandling av avluter